• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外循环冠状动脉搭桥手术中挥发性与非挥发性药物心脏保护作用的比较。

A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery.

作者信息

De Hert S, Vlasselaers D, Barbé R, Ory J-P, Dekegel D, Donnadonni R, Demeere J-L, Mulier J, Wouters P

机构信息

Division of Cardiothoracic and Vascular Anaesthesiology, Academic Medical Center, Amsterdam, Netherlands.

出版信息

Anaesthesia. 2009 Sep;64(9):953-60. doi: 10.1111/j.1365-2044.2009.06008.x.

DOI:10.1111/j.1365-2044.2009.06008.x
PMID:19686479
Abstract

A randomised study of 414 patients undergoing coronary artery surgery with cardiopulmonary bypass was conducted to compare the effects of a volatile anaesthetic regimen with either deesflurane or sevoflurane, and a total intravenous anaesthesia (TIVA) regimen on postoperative troponin T release. The primary outcome variable was postoperative troponin T release, secondary outcome variables were hospital length of stay and 1-year mortality. Maximal postoperative troponin T values did not differ between groups (TIVA: 0.30 [0.00-4.79] ng x ml(-1) (median [range]), sevoflurane: 0.33 [0.02-3.68] ng x ml(-1), and desflurane: 0.39 [0.08-3.74] ng x ml(-1)). The independent predictors of hospital length of stay were the EuroSCORE (p < 0.001), female gender (p = 0.042) and the group assignment (p < 0.001). The one-year mortality was 12.3% in the TIVA group, 3.3% in the sevoflurane group, and 6.7% in the desflurane group. The EuroSCORE (p = 0.003) was the only significant independent predictor of 1-year mortality.

摘要

一项针对414例行体外循环冠状动脉手术患者的随机研究开展,以比较使用地氟烷或七氟烷的挥发性麻醉方案与全静脉麻醉(TIVA)方案对术后肌钙蛋白T释放的影响。主要结局变量为术后肌钙蛋白T释放,次要结局变量为住院时间和1年死亡率。术后肌钙蛋白T的最大值在各组间无差异(TIVA组:0.30 [0.00 - 4.79] ng x ml⁻¹(中位数[范围]),七氟烷组:0.33 [0.02 - 3.68] ng x ml⁻¹,地氟烷组:0.39 [0.08 - 3.74] ng x ml⁻¹)。住院时间的独立预测因素为欧洲心脏手术风险评估系统(EuroSCORE)(p < 0.001)、女性性别(p = 0.042)和分组(p < 0.001)。TIVA组的1年死亡率为12.3%,七氟烷组为3.3%,地氟烷组为6.7%。欧洲心脏手术风险评估系统(p = 0.003)是1年死亡率唯一显著的独立预测因素。

相似文献

1
A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery.体外循环冠状动脉搭桥手术中挥发性与非挥发性药物心脏保护作用的比较。
Anaesthesia. 2009 Sep;64(9):953-60. doi: 10.1111/j.1365-2044.2009.06008.x.
2
Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study.冠状动脉搭桥手术中地氟醚预处理:一项双盲、随机、安慰剂对照研究。
Eur J Cardiothorac Surg. 2007 Aug;32(2):319-25. doi: 10.1016/j.ejcts.2007.05.005. Epub 2007 Jun 15.
3
The effects of interrupted or continuous administration of sevoflurane on preconditioning before cardio-pulmonary bypass in coronary artery surgery: comparison with continuous propofol.七氟醚间断或持续给药对冠状动脉手术体外循环前预处理的影响:与持续输注丙泊酚的比较
Anaesthesia. 2008 Oct;63(10):1046-55. doi: 10.1111/j.1365-2044.2008.05563.x. Epub 2008 Jul 8.
4
Myocardial protection by isoflurane vs. sevoflurane in ultra-fast-track anaesthesia for off-pump aortocoronary bypass grafting.在非体外循环主动脉冠状动脉搭桥术的超快通道麻醉中,异氟烷与七氟烷对心肌的保护作用比较
Eur J Anaesthesiol. 2008 Mar;25(3):230-6. doi: 10.1017/S0265021507002608. Epub 2007 Sep 26.
5
Isoflurane preconditioning-induced cardio-protection in patients undergoing coronary artery bypass grafting.异氟烷预处理对冠状动脉搭桥手术患者的心脏保护作用。
Eur J Anaesthesiol. 2006 Oct;23(10):841-7. doi: 10.1017/S0265021506000354. Epub 2006 Mar 1.
6
Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.挥发性麻醉剂对心脏的保护作用:一项在接受体外循环冠状动脉搭桥术患者中进行的多中心随机对照研究。
Eur J Anaesthesiol. 2007 Apr;24(4):323-31. doi: 10.1017/S0265021506001931. Epub 2006 Dec 8.
7
Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study.挥发性麻醉剂预防心肌损伤:一项多中心随机对照研究。
J Cardiothorac Vasc Anesth. 2006 Aug;20(4):477-83. doi: 10.1053/j.jvca.2006.05.012.
8
Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients.异氟烷预处理与丙泊酚后处理的协同作用可减轻患者的心肌再灌注损伤。
Clin Sci (Lond). 2011 Jul;121(2):57-69. doi: 10.1042/CS20100435.
9
Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial.远程缺血预处理在异氟醚而非丙泊酚全身麻醉下冠状动脉旁路移植术中的保护作用——一项临床试验。
Acta Anaesthesiol Scand. 2012 Jan;56(1):30-8. doi: 10.1111/j.1399-6576.2011.02585.x. Epub 2011 Nov 21.
10
Sevoflurane-remifentanil versus propofol-remifentanil anesthesia at a similar bispectral level for off-pump coronary artery surgery: no evidence of reduced myocardial ischemia.在相似脑电双频指数水平下,七氟醚-瑞芬太尼与丙泊酚-瑞芬太尼用于非体外循环冠状动脉搭桥手术麻醉的比较:无心肌缺血减轻的证据
J Cardiothorac Vasc Anesth. 2006 Aug;20(4):484-92. doi: 10.1053/j.jvca.2005.08.001. Epub 2006 Feb 2.

引用本文的文献

1
Postoperative pulmonary complications of desflurane- versus sevoflurane-based general anesthesia in patients with chronic obstructive pulmonary disease or asthma undergoing gastrointestinal cancer surgery: a nationwide retrospective cohort study.在接受胃肠道癌手术的慢性阻塞性肺疾病或哮喘患者中,地氟烷与七氟烷全身麻醉术后肺部并发症的全国性回顾性队列研究。
J Anesth. 2025 Jul 16. doi: 10.1007/s00540-025-03548-0.
2
Therapeutic strategies to ameliorate mitochondrial oxidative stress in ischaemia-reperfusion injury: A narrative review.改善缺血再灌注损伤中线粒体氧化应激的治疗策略:一项叙述性综述。
Clin Sci (Lond). 2025 Feb 3;139(3):CS20242074. doi: 10.1042/CS20242074.
3
Cardioprotective Efficacy of Sevoflurane in Patients With Rheumatic Heart Disease Undergoing Heart Valve Surgery Under Cardiopulmonary Bypass.
七氟醚对风湿性心脏病患者体外循环心脏瓣膜手术的心脏保护作用
J Saudi Heart Assoc. 2024 Aug 1;36(2):120-127. doi: 10.37616/2212-5043.1384. eCollection 2024.
4
Desflurane Versus Sevoflurane and Postoperative Cardiac Biomarkers in Older Adults Undergoing Low- to Moderate-Risk Noncardiac Surgery-Secondary Analysis of a Prospective, Observer-Blinded, Randomized Clinical Trial.地氟烷与七氟烷及低至中度风险非心脏手术老年患者术后心脏生物标志物——一项前瞻性、观察者盲法、随机临床试验的二次分析
J Clin Med. 2024 Oct 6;13(19):5946. doi: 10.3390/jcm13195946.
5
Volatile versus Total Intravenous Anesthesia for Coronary Artery Bypass Graft Surgery: Analysis of 1586 MYRIAD Trial Patients Managed with the Same Perioperative Protocol.冠状动脉搭桥手术中挥发性麻醉与全静脉麻醉的比较:对1586例采用相同围手术期方案管理的MYRIAD试验患者的分析。
Rev Cardiovasc Med. 2022 Jul 21;23(8):265. doi: 10.31083/j.rcm2308265. eCollection 2022 Aug.
6
Myocardial protection in cardiac surgery: a comprehensive review of current therapies and future cardioprotective strategies.心脏手术中的心肌保护:当前治疗方法与未来心脏保护策略的全面综述
Front Med (Lausanne). 2024 Jun 19;11:1424188. doi: 10.3389/fmed.2024.1424188. eCollection 2024.
7
Comparison between propofol and total inhalational anaesthesia on cardiovascular outcomes following on-pump cardiac surgery in higher-risk patients: a randomised controlled pilot and feasibility study.在高风险患者行体外循环心脏手术后,比较异丙酚和全吸入麻醉对心血管结局的影响:一项随机对照的先导和可行性研究。
Open Heart. 2024 May 9;11(1):e002630. doi: 10.1136/openhrt-2024-002630.
8
Postoperative outcomes after total sevoflurane inhalation sedation using a disposable delivery system (Sedaconda-ACD) in cardiac surgery.在心脏手术中使用一次性输送系统(Sedaconda-ACD)进行全七氟醚吸入镇静后的术后结果。
Front Med (Lausanne). 2024 Mar 5;11:1340119. doi: 10.3389/fmed.2024.1340119. eCollection 2024.
9
An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases.蛋白激酶作为治疗靶点的最新研究进展——第一部分:蛋白激酶 C 的激活及其在癌症和心血管疾病中的作用。
Int J Mol Sci. 2023 Dec 18;24(24):17600. doi: 10.3390/ijms242417600.
10
Beneficial Effects of Halogenated Anesthetics in Cardiomyocytes: The Role of Mitochondria.卤代麻醉剂对心肌细胞的有益作用:线粒体的作用。
Antioxidants (Basel). 2023 Sep 30;12(10):1819. doi: 10.3390/antiox12101819.